STAAR SURGICAL CO
For the period ended Dec 27, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| STAAR SURGICAL COMPANY | ||
| Date: February 21, 2025 | By: | /s/ THOMAS G. FRINZI |
|---|---|---|
| Thomas G. Frinzi | ||
| President, Chief Executive Officer and Chair of the Board | ||
| (principal executive officer) | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ THOMAS G. FRINZI | President, Chief Executive Officer and Chair of the Board, Director | February 21, 2025 |
| Thomas G. Frinzi | (principal executive officer) | |
| /s/ PATRICK F. WILLIAMS | Vice President, Chief Financial Officer | February 21, 2025 |
| Patrick F. Williams | (principal accounting and financial officer) | |
| /s/ ARTHER C. BUTCHER | Director | February 21, 2025 |
| Arthur C. Butcher | ||
| /s/ STEPHEN C. FARRELL | Director | February 21, 2025 |
| Stephen C. Farrell | ||
| /s/ WEI JIANG | Director | February 21, 2025 |
| Wei Jiang | ||
| /s/ AIMEE S. WEISNER | Director | February 21, 2025 |
| Aimee S. Weisner | ||
| /s/ ELIZABETH YEU | Director | February 21, 2025 |
| Elizabeth Yeu | ||
| /s/ LILIAN ZHOU | Director | February 21, 2025 |
| Lilian Zhou | ||
CONSOLIDATED FINANCIAL STATEMENTS
TABLE OF CONTENTS
| Report of Independent Registered Public Accounting Firm (BDO USA, P.C.; Los Angeles, California; PCAOB ID#243) | F-2 |
|---|---|
| Consolidated Balance Sheets at December 27, 2024 and December 29, 2023 | F-4 |
| Consolidated Statements of Operations for the years ended December 27, 2024, December 29, 2023 and December 30, 2022 | F-5 |
| Consolidated Statements of Comprehensive Income (Loss) for the years ended December 27, 2024, December 29, 2023 and December 30, 2022 | F-6 |
| Consolidated Statements of Stockholders’ Equity for the years ended December 27, 2024, December 29, 2023 and December 30, 2022 | F-7 |
| Consolidated Statements of Cash Flows for the years ended December 27, 2024, December 29, 2023 and December 30, 2022 | F-8 |
| Notes to Consolidated Financial Statements | F-9 |
| Schedule II Valuation and Qualifying Accounts and Reserves | F-40 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.